PHILIPPINES

RePORT Philippines (Regional Prospective Observational Research for Tuberculosis) is a multi-organizational, collaborative effort that was initiated by the Philippine Council for Health Research and Development (PCHRD) of the Department of Science and Technology (DOST) in August 2017 through a Memorandum of Understanding with the National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH). The aim of the establishment of the consortium was to serve as foundation for national and international collaborations to facilitate communication in the collection, dissemination and sharing of information and knowledge on tuberculosis. This ties in with the role of PCHRD to promote discovery, development and marketing of novel drugs, diagnostic tests, vaccines, and other health technologies to foster a healthier and more productive nation. Funding and management of the consortium is provided by the Philippine Department of Science and Technology (DOST) and its agency, the Philippine Council for Health Research and Development (PCHRD).

 

RePORT Philippines has two sites- the University of the Philippines Manila- National Institutes of Health (UPM- NIH) and the De La Salle Medical and Health Sciences Institute (DLSMHSI). Both sites have their own individual parent protocols which incorporate the RePORT common protocol. UPM-NIH has started study enrolment in June 2018 while DLSMHSI is currently in preparations for the start of their study.

The DLSMHSI COACH – DRTB Strategy, will support the RePORT International Consortium by conducting a local groundbreaking project involving intensified case finding utilizing the Kagabay community workers to identify active DRTB cases and latent TB among DRTB contacts of bacteriologically confirmed cases with assessment factors for poor treatment outcome. The project will also focus on the social value of the study and emphasized that the monitoring of adherence is an innovation involving BHW as front liners and with patient advantages compared to DOT.

In support of RePORT International, the study will also collect patient specimens for future biomarkers studies.

LINKS

US-NLM-PubMed-Logo.svg.png

For a more comprehensive and up to date research bibliography visit our PubMed bibliography here.

For regional journal publications, please click here.